The Valley Desk

NCT05616793 · Interventional trial

Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions LCA5

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov